基因编辑权威指南。
菜单
首页 学习 新闻 向 Atlas 提问
探索 技术 疾病 治疗方法 临床试验 企业 科学家 基因 研究 机构
医学之外 农业 伦理 投资 世界地图
学习与工具 从这里开始 术语表 A–Z 对比技术 时间线 列表与排名 AI 智能体 ★ 已保存 API
关于 关于我们 方法论 数据来源 编辑方针 联系我们 免责声明

🧭 引导视图
遗传学新手?浏览时我们会用简单易懂的语言为您解释每个术语,就在同一页面内,帮助随时可用。

⚡ 专家观点
你已经了解生物学基础,只需内容本身——简洁明了,无额外解释。这是默认视图。

界面语言
浅色模式

Treatments

Most Advanced CRISPR Treatments

Every treatment in the Atlas ordered by how far it has progressed.

本列表的构建方式

The full treatment database sorted by development stage, from approved medicines down to programmes that have been discontinued.

#词条分类 状态
1 Casgevy (exagamglogene autotemcel) The first CRISPR-based medicine approved anywhere in the world — a one-time therapy made… Sickle cell disease; beta thalassemia Approved
2 Lyfgenia (lovotibeglogene autotemcel) Approved on the same day as Casgevy for sickle cell disease — but a gene-addition… Sickle cell disease Approved
3 Zynteglo (betibeglogene autotemcel) An approved gene-addition therapy for transfusion-dependent beta thalassemia — the… Beta thalassemia Approved
4 Nexiguran ziclumeran (nex-z) The first CRISPR therapy ever administered into a human bloodstream — a single infusion… ATTR amyloidosis Phase III
5 Lonvoguran ziclumeran (lonvo-z) The first in vivo gene-editing therapy to report a positive Phase 3 result — a single… Hereditary angioedema Phase III
6 Risto-cel (BEAM-101) A base-editing therapy for sickle cell disease that mimics a naturally protective genetic… Sickle cell disease Phase III
7 BEAM-302 The first therapy to correct a disease-causing point mutation inside a living person — a… Alpha-1 antitrypsin deficiency Phase III
8 VERVE-102 A one-time base-editing infusion intended to lower LDL cholesterol permanently by… Familial hypercholesterolemia Phase II
9 PM359 The first prime-editing therapy given to human patients, with published evidence that it… Chronic granulomatous disease Phase I/II
10 EDIT-401 Editas Medicine's lead in vivo candidate after abandoning its cell-therapy programmes —… Familial hypercholesterolemia Preclinical
11 CTX112 An allogeneic CD19 CAR-T candidate with multiple CRISPR edits intended to make one… Cancer Phase I/II
12 CB-010 An allogeneic CAR-T candidate built with hybrid RNA-DNA guides rather than conventional… Cancer Phase I
13 EDIT-101 (Brilliance) The first CRISPR therapy injected directly into a human organ — scientifically… Inherited blindness Discontinued
14 Bespoke base editor for CPS1 deficiency (the KJ Muldoon case) A gene-editing medicine designed, manufactured and administered for a single infant in… Rare genetic disease Completed
15 Hypoimmune islet cell therapy Transplanted insulin-producing cells edited to be invisible to the immune system, so they… Diabetes Phase I
这份列表无法告诉你什么Stage is the most advanced publicly reported stage as of each record's last-updated date.
Written by The CRISPR Atlas editorial team Last updated Aug 25, 2026